Insider Trading Summary for Exelixis, Inc. (EXEL): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
06-Jun-24 8:37 PM View:	04-Jun-24 Private Sale (Planned) ($182.31K)	Wyszomierski Jack L Director		Exelixis, Inc. - EXEL	3% 338.19K to 349.5K	0	0	--	--	Show Txns Hide Txns

04-Jun-24 8:21 PM View:	31-May-24 Grant 0	Papadopoulos Stelios Director		Exelixis, Inc. - EXEL	2% 1.26M to 1.28M	0	0	--	--	Show Txns Hide Txns

12-Aug-24 7:22 PM View:	08-Aug-24 Private Sale ($906.86K)	Poste George Director		Exelixis, Inc. - EXEL	(7%) 213.91K to 199.02K	0	0	--	--	Show Txns Hide Txns

25-Mar-24 7:31 PM View:	21-Mar-24 Planned Private Option Sale ($461.11K)	Garber Alan M Director		Exelixis, Inc. - EXEL	14% 31.42K to 35.7K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 8:03 PM View:	15-Nov-24 Payment of Exercise ($1.67M)	Morrissey Michael M President and CEO Director		Exelixis, Inc. - EXEL	13% 2.06M to 2.34M	0	0	--	--	Show Txns Hide Txns

19-Nov-24 8:03 PM View:	15-Nov-24 Payment of Exercise ($613.58K)	Senner Christopher J. EVP and CFO		Exelixis, Inc. - EXEL	15% 614.27K to 706.9K	0	0	--	--	Show Txns Hide Txns

15-Aug-24 8:18 PM View:	13-Aug-24 Disposition (other) 0	Smith Julie Director		Exelixis, Inc. - EXEL	(67%) 32.73K to 10.78K	0	0	--	--	Show Txns Hide Txns

16-Aug-24 7:35 PM View:	14-Aug-24 Private Sale ($219.12K)	Freire Maria C Director		Exelixis, Inc. - EXEL	13% 80.42K to 91.01K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 8:03 PM View:	18-Nov-24 Sale (Planned) ($761.92K)	Haley Patrick J. EVP, Commercial		Exelixis, Inc. - EXEL	(9%) 356.02K to 322.85K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 8:02 PM View:	15-Nov-24 Payment of Exercise ($449.97K)	Aftab Dana CSO/EVP Disc & Trans Research		Exelixis, Inc. - EXEL	11% 443.88K to 491.94K	0	0	--	--	Show Txns Hide Txns

30-May-24 7:50 PM View:	30-May-24 Purchase $4.67M	Johnson David Edward Director		Exelixis, Inc. - EXEL	66% 928.91K to 1.54M	0	0	--	--	Show Txns Hide Txns

04-Jun-24 8:20 PM View:	31-May-24 Grant 0	Heyman Tomas J. Director		Exelixis, Inc. - EXEL	104% 18.18K to 37.01K	0	0	--	--	Show Txns Hide Txns

04-Jun-24 8:20 PM View:	31-May-24 Grant 0	Oliver Bob Director		Exelixis, Inc. - EXEL	104% 18.18K to 37.01K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 6:59 PM View:	23-Feb-24 Grant 0	Peterson Amy C. EVP Prod Dev & Med Aff & CMO		Exelixis, Inc. - EXEL	34% 240.0K to 322.12K	0	0	--	--	Show Txns Hide Txns

04-Jun-24 8:19 PM View:	31-May-24 Grant 0	Beckerle Mary C Director		Exelixis, Inc. - EXEL	100% 0 to 34.26K	0	0	--	--	Show Txns Hide Txns

04-Jun-24 8:19 PM View:	31-May-24 Grant 0	Eckhardt Sue Gail Director		Exelixis, Inc. - EXEL	100% 0 to 34.26K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 8:03 PM View:	15-Nov-24 Payment of Exercise ($514.25K)	Hessekiel Jeffrey EVP & General Counsel		Exelixis, Inc. - EXEL	(15%) 609.34K to 516.65K	0	0	--	--	Show Txns Hide Txns

Exelixis, Inc. (EXEL)

Last Year

22-Nov-23 -- 21-Nov-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--